GlassScriptPhysician profile
Elizabeth Steinberg
NPI 1396962924
$1,172.39
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $58.37 · 2021: $234 · 2022: $308 · 2023: $355 · 2024: $55.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $221 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $220.68 |
| Education | $189.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $304.84 | 2021-2023 | Tremfya, Simponi, Simponi Aria |
| Lilly USA, LLC | $259.16 | 2019-2024 | Taltz, Olumiant |
| Leo Pharma INC. | $116.27 | 2019-2022 | |
| Incyte Corporation | $115.48 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $92.65 | 2019-2023 | |
| Ucb, INC. | $73.78 | 2021 | |
| Abbvie INC. | $58.22 | 2021 | |
| Almirall LLC | $40.39 | 2022 | |
| Sebela Pharmaceuticals INC. | $30.72 | 2019-2022 | |
| Prugen, INC. Pharmaceuticals | $25.95 | 2019 | |
| Pfizer INC. | $22.93 | 2023 | |
| Galderma Laboratories, L.P. | $20.06 | 2022 | |
| Mission Pharmacal Company | $11.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Steinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.